Crohn’s & Colitis Foundation Launches 2026 “Spill Your Guts” PSA, Spotlighting Real IBD Stories to Break Stigma
PR Newswire
NEW YORK, June 10, 2026
NEW YORK, June 10, 2026 /PRNewswire/ — The Crohn’s & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving the quality of life for the 1 in 100 Americans living with these diseases, today launched a powerful new public service announcement (PSA) campaign featuring four people living with Crohn’s disease and ulcerative colitis in candid conversation about life with an invisible illness.
In the new “Spill Your Guts” spots, participants openly discuss the challenges of living with Crohn’s disease and ulcerative colitis—how they may appear fine on the outside while managing serious physical symptoms and the often unseen mental toll. Their stories encourage people who may be suffering in silence to speak up and recognize they’re not alone. Through these shared experiences, the Foundation aims to raise awareness of IBD, prompt those experiencing symptoms to seek medical guidance, and inspire individuals with a diagnosis to connect with the organization for support.
The 2026 PSAs spotlight four individuals: Rob Nunnery, a professional pickleball player living in South Africa with perianal Crohn’s disease and a permanent ostomy; Sara Levitt, a Montreal-based content creator and model living with Crohn’s disease and a permanent ostomy; Saxl Rose (Antonio Hancock), a musician from Lancaster, Pennsylvania who has played with Paramore and Wiz Khalifa while managing Crohn’s disease; and Victoria Tyler, a Dallas, Texas-based influencer and patient advocate living with ulcerative colitis and a permanent ostomy. Through their stories, the campaign puts real faces and lived experience at the center of the conversation around IBD.
Inflammatory bowel disease (IBD) which includes Crohn’s disease and ulcerative colitis is a lifelong disease that causes ongoing inflammation in the gastrointestinal tract and can lead to symptoms like urgent diarrhea, stomach pain, fatigue, and weight loss. Because these symptoms involve bathroom issues and topics many people feel embarrassed to discuss, there is often silence, misunderstanding, and stigma around IBD, which can keep people from getting diagnosed, receiving support, or seeking timely medical care.
“The more we amplify real stories from people like Rob, Sara, Saxl, and Victoria, the more we help others recognize symptoms, feel less alone, and take the important step of seeking care,” said Michael Osso, President and CEO of the Crohn’s & Colitis Foundation. “These PSAs bring to light what is too often hidden about life with IBD—the physical challenges and emotional burden—while encouraging anyone affected, including those who may be undiagnosed, to reach out to the Crohn’s & Colitis Foundation for support and guidance.”
The Foundation is committed to reducing IBD stigma through bold, open dialogue while providing comprehensive support and education for patients and healthcare professionals.
The PSAs were developed in partnership with Olixir NY (Formerly FCB). For more on IBD and the campaign, visit www.spillyourguts.org.
To schedule an interview with Crohn’s & Colitis Foundation President and CEO Michael Osso, or one of the individuals featured in the PSAs, please contact media@crohnscolitisfoundation.org.
The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.
View original content:https://www.prnewswire.com/news-releases/crohns–colitis-foundation-launches-2026-spill-your-guts-psa-spotlighting-real-ibd-stories-to-break-stigma-302796992.html
SOURCE Crohn’s & Colitis Foundation
